Caffeine Market Report 2018 Puts Limelight on Key Drivers, Challenges, Opportunities and Competitive Landscape

Radiant Insights, Inc.

SAN FRANCISCO, December 4, 2018 /PRNewswire/ --

Global Caffeine Market is estimated to grow at a substantial CAGR of 2.5% by 2022 as the scope, product types, and its applications are increasing across the globe. Caffeine belongs to "methylxanthine class". It acts as a stimulant to central nervous system (CNS). It is the world's most extensively consumed psychoactive drug. The factors that propel the growth of the Caffeine Market include the facts that the intake of caffeine improves concentration, enhances performance, and lowers the risk of cardiovascular disease, colon, liver, and colorectal cancers. Improved consciousness regarding health has led to surge in consumption of sports drinks; that have concentrations of caffeine. On the other hand, there are factors that may hamper the growth of the market including health hazards such as surge in blood sugar levels; which, in turn, proves to be detrimental for people with type 2 diabetes (as insulin level goes in for a toss), along with price variation, and climate change.

Caffeine Market may be explored by product type, applications, and geography. Caffeine Market may be explored by product type as Natural Caffeine, and Synthesis Caffeine. Caffeine Market could be explored based on applications as Food & Beverage, Cosmetic, and Pharmaceutical. Caffeine Market is categorized based on geography into North America, Latin America, Japan, Middle East and Africa, Western Europe, Asia Pacific, and Eastern Europe. North America accounted for the major share of the Caffeine Market Size in 2017 and will continue to lead in the forecast period. The key players contributing to the robust growth of the Caffeine Market comprise Bioprocess Algae, DSM Nutritional Products, Qualitas Health, Source-Omega, Neptune Wellness Solutions (Biogroga), Simris Alg, Algaecides, ADM, Nordic Naturals, Polaris, Algisy, Terravia (Solazyme), Nature's Way (Ascenta Health), Xiamen Huison Biotech, and Synthetic Genomics, Bioceuticals. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.